
EXAS+121.00%25.0%

GH+178.00%25.0%

GRAL+132.30%25.0%

XGN-21.58%25.0%
As of Aug 24, 2026, 4:53 AM ET
MedTech Long '25: Centralized Lab Diagnostics Constituents
Exact Sciences CorporationEXAS | 25.0% | 0.00% | 0.00% | 0.00% | 0.00% | 3.30% | 1.48% | 135.44% | 75.73% | 7.50% | 121.00% | $20.03B |
Exagen Inc.XGN | 25.0% | 1.80% | 16.99% | 69.23% | 74.83% | 30.26% | 118.78% | 78.78% | 153.85% | -41.98% | -21.58% | $191.3M |
GRAIL Inc.GRAL | 25.0% | 2.01% | 5.38% | 17.25% | 16.02% | -7.07% | 49.43% | 204.28% | 416.16% | 291.44% | 132.30% | $3.41B |
Guardant Health, Inc.GH | 25.0% | 1.67% | 3.39% | 15.86% | 5.37% | 67.11% | 81.78% | 292.48% | 488.18% | 57.26% | 178.00% | $22.91B |
| Theme return | — | 1.37% | 6.44% | 20.88% | 22.63% | 36.24% | 66.59% | 235.20% | 387.89% | 195.21% | 120.46% | — |
| Average | 25.0% | 1.37% | 6.44% | 25.59% | 24.06% | 23.40% | 62.87% | 177.75% | 283.48% | 78.55% | 102.43% | $11.63B |
| Median | 25.0% | 1.74% | 4.39% | 16.56% | 10.70% | 16.78% | 65.61% | 169.86% | 285.00% | 32.38% | 126.65% | $11.72B |
| Std Dev | 0.0% | 0.80% | 6.39% | 26.09% | 29.88% | 28.68% | 43.11% | 79.77% | 172.82% | 127.82% | 74.71% | $9.95B |
| Min | 25.0% | 0.00% | 0.00% | 0.00% | 0.00% | -7.07% | 1.48% | 78.78% | 75.73% | -41.98% | -21.58% | $191.3M |
| Max | 25.0% | 2.01% | 16.99% | 69.23% | 74.83% | 67.11% | 118.78% | 292.48% | 488.18% | 291.44% | 178.00% | $22.91B |
| % Positive Tickers | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 100.00% | 100.00% | 100.00% | 75.00% | 75.00% |
About this theme
MedTech Long '25: Centralized Lab Diagnostics tracks 4 publicly listed stocks in this theme: EXAS, GH, GRAL, XGN. See the constituent table for details.
